https://pipelinereview.com/Aura-Biosciences-Announces-Initiation-of-Phase-1b-Clinical-Trial-and-Receipt-of-FDA-Fast-Track-Designation-for-AU-011-for-the-Treatment-of-Primary-Ocular-Melanoma/